Breaking News Instant updates and real-time market news.

SBGI

Sinclair Broadcast

$16.81 /

-0.68 (-3.89%)

09:51
03/30/20
03/30
09:51
03/30/20
09:51

Sinclair Broadcast trading resumes

  • 20

    Apr

SBGI Sinclair Broadcast
$16.81 /

-0.68 (-3.89%)

02/27/20 B. Riley FBR
Sinclair shares oversold as stations still have value, says B. Riley FBR
01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
12/13/19 JPMorgan
Sinclair Broadcast reinstated with a Neutral at JPMorgan
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle

TODAY'S FREE FLY STORIES

Hot Stocks
Sky Solar announces receipt of preliminary non-binding proposal » 08:37
05/26/20
05/26
08:37
05/26/20
08:37
SKYS

Sky Solar

$3.30 /

-0.09 (-2.65%)

Sky Solar Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKYS Sky Solar
$3.30 /

-0.09 (-2.65%)

Syndicate
TransMedics announces proposed public offering of common stock » 08:36
05/26/20
05/26
08:36
05/26/20
08:36
TMDX

TransMedics

$16.01 /

+0.55 (+3.56%)

TransMedics Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMDX TransMedics
$16.01 /

+0.55 (+3.56%)

TMDX TransMedics
$16.01 /

+0.55 (+3.56%)

04/06/20 Oppenheimer
Oppenheimer starts TransMedics with Outperform, $25 price target
04/06/20 Oppenheimer
TransMedics initiated with an Outperform at Oppenheimer
11/07/19 Cowen
TransMedics price target lowered to $28 from $40 at Cowen
10/07/19 Cowen
TransMedics weakness a buying opportunity, says Cowen
TMDX TransMedics
$16.01 /

+0.55 (+3.56%)

TMDX TransMedics
$16.01 /

+0.55 (+3.56%)

Hot Stocks
Durect announces results from Phase 1b clinical study of DUR-928 » 08:36
05/26/20
05/26
08:36
05/26/20
08:36
DRRX

Durect

$2.47 /

-0.06 (-2.37%)

DURECT announced positive…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$2.47 /

-0.06 (-2.37%)

DRRX Durect
$2.47 /

-0.06 (-2.37%)

05/12/20 Cantor Fitzgerald
Durect risk/reward 'highly favorable' into Posimir decision, says Cantor
03/04/20 Cantor Fitzgerald
Cantor reiterates Overweight on Durect with $5 target post results
01/31/20 B. Riley FBR
B. Riley FBR starts Durect with Buy rating, $5 price target
01/31/20 B. Riley FBR
Durect initiated with a Buy at B. Riley FBR
DRRX Durect
$2.47 /

-0.06 (-2.37%)

DRRX Durect
$2.47 /

-0.06 (-2.37%)

DRRX Durect
$2.47 /

-0.06 (-2.37%)

DRRX Durect
$2.47 /

-0.06 (-2.37%)

Syndicate
Viela Bio announces proposed offering of common stock » 08:35
05/26/20
05/26
08:35
05/26/20
08:35
VIE

Viela Bio

$60.14 /

+0.755 (+1.27%)

Viela Bio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIE Viela Bio
$60.14 /

+0.755 (+1.27%)

VIE Viela Bio
$60.14 /

+0.755 (+1.27%)

05/14/20 Guggenheim
Viela Bio price target raised to $78 from $51 at Guggenheim
05/14/20 H.C. Wainwright
Viela Bio price target raised to $70 from $60 at H.C. Wainwright
04/29/20
Fly Intel: Top five analyst initiations
04/29/20 Wedbush
Wedbush bullish on Viela Bio, initiates with an Outperform
VIE Viela Bio
$60.14 /

+0.755 (+1.27%)

VIE Viela Bio
$60.14 /

+0.755 (+1.27%)

Hot Stocks
Beyond Air receives approval from Health Canada to study nitric oxide » 08:35
05/26/20
05/26
08:35
05/26/20
08:35
XAIR

Beyond Air

$8.06 /

-0.2 (-2.42%)

Beyond Air announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XAIR Beyond Air
$8.06 /

-0.2 (-2.42%)

XAIR Beyond Air
$8.06 /

-0.2 (-2.42%)

10/21/19 Oppenheimer
Oppenheimer starts Beyond Air with Outperform rating, $9 price target
10/21/19 Oppenheimer
Beyond Air initiated with an Outperform at Oppenheimer
XAIR Beyond Air
$8.06 /

-0.2 (-2.42%)

General news
Chicago Fed National Activity Index 3 Month Moving Average data reported » 08:35
05/26/20
05/26
08:35
05/26/20
08:35

April Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Chicago Fed National Activity Index Level data reported » 08:35
05/26/20
05/26
08:35
05/26/20
08:35

April Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Cirrus Logic price target raised to $82 from $80 at Stifel » 08:33
05/26/20
05/26
08:33
05/26/20
08:33
CRUS

Cirrus Logic

$73.40 /

+0.09 (+0.12%)

, AAPL

Apple

$318.75 /

+1.83 (+0.58%)

Stifel analyst Tore…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

05/05/20 Susquehanna
Cirrus Logic price target raised to $84 from $82 at Susquehanna
05/04/20 KeyBanc
Apple cautious iPhone outlook likely a headwind for chip suppliers, says KeyBanc
03/31/20
upgraded Fly Intel: Top five analyst upgrades
03/31/20 BofA
Cirrus Logic double-upgraded to Buy from Underperform at BofA
AAPL Apple
$318.75 /

+1.83 (+0.58%)

08:14 Today Cowen
Apple checks suggest four new iPhones this year, says Cowen
05/18/20 Wedbush
Apple yet again caught in U.S./China Tensions, says Wedbush
05/12/20 Wedbush
Apple price target raised to $350 from $335 at Wedbush
05/07/20 Bernstein
Google payments to Apple big, predicated on advertising, says Bernstein
CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

Hot Stocks
Auris Medical announces data from AM-201 Phase 1b study » 08:33
05/26/20
05/26
08:33
05/26/20
08:33
EARS

Auris Medical

$1.10 /

+ (+0.00%)

Auris Medical Holding…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EARS Auris Medical
$1.10 /

+ (+0.00%)

EARS Auris Medical
$1.10 /

+ (+0.00%)

Hot Stocks
NeuroBo receives notice from FDA regarding development program for Gemcabene » 08:32
05/26/20
05/26
08:32
05/26/20
08:32
NRBO

NeuroBo Pharmaceuticals

$13.53 /

-0.32 (-2.31%)

NeuroBo Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRBO NeuroBo Pharmaceuticals
$13.53 /

-0.32 (-2.31%)

NRBO NeuroBo Pharmaceuticals
$13.53 /

-0.32 (-2.31%)

02/18/20 Ladenburg
NeuroBo Pharmaceuticals initiated with a Buy at Ladenburg
NRBO NeuroBo Pharmaceuticals
$13.53 /

-0.32 (-2.31%)

Recommendations
Synnex price target raised to $115 from $96 at Barrington » 08:32
05/26/20
05/26
08:32
05/26/20
08:32
SNX

Synnex

$100.23 /

-0.92 (-0.91%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNX Synnex
$100.23 /

-0.92 (-0.91%)

SNX Synnex
$100.23 /

-0.92 (-0.91%)

04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
03/25/20 Barrington
Synnex price target lowered to $96 from $150 at Barrington
03/25/20 Cross Research
Synnex downgraded to Hold from Buy at Cross Research
03/25/20 Raymond James
Synnex price target lowered to $120 from $165 at Raymond James
SNX Synnex
$100.23 /

-0.92 (-0.91%)

SNX Synnex
$100.23 /

-0.92 (-0.91%)

SNX Synnex
$100.23 /

-0.92 (-0.91%)

Hot Stocks
Arena Pharmaceuticals completes full enrollment in Phase 2 ADVISE trial » 08:32
05/26/20
05/26
08:32
05/26/20
08:32
ARNA

Arena Pharmaceuticals

$58.93 /

+1.51 (+2.63%)

Arena Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$58.93 /

+1.51 (+2.63%)

ARNA Arena Pharmaceuticals
$58.93 /

+1.51 (+2.63%)

05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Jefferies
Arena Pharmaceuticals initiated with a Buy at Jefferies
05/18/20 Jefferies
Arena Pharmaceuticals initiated with a Buy at Jefferies
03/31/20 Guggenheim
Guggenheim starts Arena at Buy on 'pipeline-in-a-product' etrasimod
ARNA Arena Pharmaceuticals
$58.93 /

+1.51 (+2.63%)

ARNA Arena Pharmaceuticals
$58.93 /

+1.51 (+2.63%)

Hot Stocks
Protara Therapeutics receives Fast Track designation for IV Choline Chloride » 08:31
05/26/20
05/26
08:31
05/26/20
08:31
TARA

Protara Therapeutics

$40.55 /

+5.05 (+14.23%)

Protara Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TARA Protara Therapeutics
$40.55 /

+5.05 (+14.23%)

TARA Protara Therapeutics
$40.55 /

+5.05 (+14.23%)

01/22/20 Ladenburg
ArTara Therapeutics initiated with a Buy at Ladenburg
TARA Protara Therapeutics
$40.55 /

+5.05 (+14.23%)

Upgrade
Ollie's Bargain Outlet upgraded to Buy at Craig-Hallum » 08:31
05/26/20
05/26
08:31
05/26/20
08:31
OLLI

Ollie's Bargain Outlet

$85.55 /

+2.07 (+2.48%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

07:22 Today Craig-Hallum
Ollie's Bargain Outlet upgraded to Buy from Hold at Craig-Hallum
06:04 Today Credit Suisse
Ollie's Bargain Outlet downgraded to Neutral from Outperform at Credit Suisse
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 KeyBanc
Ollie's Bargain Outlet price target raised to $80 from $74 at KeyBanc
OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

Options
One option delisting on May 26th » 08:30
05/26/20
05/26
08:30
05/26/20
08:30

Option delistings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Splunk price target raised to $215 from $156 at Argus » 08:28
05/26/20
05/26
08:28
05/26/20
08:28
SPLK

Splunk

$184.37 /

+21.1 (+12.92%)

Argus analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

05/22/20 JMP Securities
Splunk price target raised to $200 from $155 at JMP Securities
05/22/20 JPMorgan
Splunk price target raised to $190 from $174 at JPMorgan
05/22/20 Raymond James
Splunk price target raised to $185 from $140 at Raymond James
05/22/20 Oppenheimer
Splunk price target raised to $190 from $145 at Oppenheimer
SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

Conference/Events
Evofem to hold a pharmaceutical update conference call » 08:25
05/26/20
05/26
08:25
05/26/20
08:25
EVFM

Evofem

$4.98 /

+0.18 (+3.75%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVFM Evofem
$4.98 /

+0.18 (+3.75%)

EVFM Evofem
$4.98 /

+0.18 (+3.75%)

04/16/20 Roth Capital
Roth believes Evofem 'underappreciated' ahead of Phexxi PDUFA date
12/18/19 Roth Capital
Evofem's Amphora getting closer to FDA approval, says Roth Capital
12/11/19 H.C. Wainwright
Evofem price target raised to $11 from $9 at H.C. Wainwright
10/16/19 Cantor Fitzgerald
Evofem assumed with an Overweight at Cantor Fitzgerald
EVFM Evofem
$4.98 /

+0.18 (+3.75%)

Syndicate
Caladrius announces $4.3M registered direct offering priced at-the-market » 08:24
05/26/20
05/26
08:24
05/26/20
08:24
CLBS

Caladrius

$2.08 /

+0.16 (+8.33%)

Caladrius Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

05/22/20 Brookline
Caladrius initiated with a Buy at Brookline
05/18/20 Dawson James
Caladrius downgraded to Neutral from Buy at Dawson James
CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

Recommendations
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink » 08:24
05/26/20
05/26
08:24
05/26/20
08:24
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

06:29 Today Wells Fargo
Regeneron upgraded to Overweight at Wells Fargo on EYLEA Survey
04:44 Today Wells Fargo
Regeneron upgraded to Overweight from Equal Weight at Wells Fargo
05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

Hot Stocks
Driver sends letter to First United Corp shareholders » 08:23
05/26/20
05/26
08:23
05/26/20
08:23
FUNC

First United Corp

$13.75 /

-0.31 (-2.20%)

Driver, one of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUNC First United Corp
$13.75 /

-0.31 (-2.20%)

Syndicate
Outlook Therapeutics announces $16M private placement for ONS-5010 development » 08:23
05/26/20
05/26
08:23
05/26/20
08:23
OTLK

Outlook Therapeutics

$0.74 /

+0.009 (+1.24%)

Outlook Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTLK Outlook Therapeutics
$0.74 /

+0.009 (+1.24%)

OTLK Outlook Therapeutics
$0.74 /

+0.009 (+1.24%)

05/05/20 Brookline
Outlook Therapeutics initiated with a Buy at Brookline
04/14/20 H.C. Wainwright
Outlook's NORSE-1 remaining on track 'comes as a relief,' says H.C. Wainwright
09/11/19 Ladenburg
Outlook Therapeutics initiated with a Buy at Ladenburg
07/18/19 H.C. Wainwright
Outlook Therapeutics initiated with a Buy at H.C. Wainwright
OTLK Outlook Therapeutics
$0.74 /

+0.009 (+1.24%)

Upgrade
Linde plc upgraded to Buy from Hold at Argus » 08:22
05/26/20
05/26
08:22
05/26/20
08:22
LIN

Linde plc

$190.98 /

-2.615 (-1.35%)

Argus analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIN Linde plc
$190.98 /

-2.615 (-1.35%)

LIN Linde plc
$190.98 /

-2.615 (-1.35%)

05/18/20 UBS
Linde plc price target raised to EUR 200 from EUR 190 at UBS
05/06/20 Berenberg
Linde plc price target lowered to EUR 215 from EUR 225 at Berenberg
04/15/20
Fly Intel: Top five analyst upgrades
04/15/20 Bernstein
Linde plc upgraded to Market Perform from Underperform at Bernstein
LIN Linde plc
$190.98 /

-2.615 (-1.35%)

LIN Linde plc
$190.98 /

-2.615 (-1.35%)

LIN Linde plc
$190.98 /

-2.615 (-1.35%)

LIN Linde plc
$190.98 /

-2.615 (-1.35%)

Recommendations
Ciena has 'at least a one-year lead' with Waveserver 5, says Jefferies » 08:22
05/26/20
05/26
08:22
05/26/20
08:22
CIEN

Ciena

$52.81 /

+1.05 (+2.03%)

Jefferies analyst George…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CIEN Ciena
$52.81 /

+1.05 (+2.03%)

CIEN Ciena
$52.81 /

+1.05 (+2.03%)

05/22/20 MKM Partners
Ciena price target raised to $62 from $54 at MKM Partners
05/13/20 B. Riley FBR
Ciena downgraded to Neutral on marco uncertainty at B. Riley FBR
05/13/20 B. Riley FBR
Ciena downgraded to Neutral from Buy at B. Riley FBR
04/16/20 Morgan Stanley
Ciena downgraded to Equal Weight on installation challenges at Morgan Stanley
CIEN Ciena
$52.81 /

+1.05 (+2.03%)

CIEN Ciena
$52.81 /

+1.05 (+2.03%)

CIEN Ciena
$52.81 /

+1.05 (+2.03%)

CIEN Ciena
$52.81 /

+1.05 (+2.03%)

Hot Stocks
Edison Nation acquires 50% interest in Global Clean Solutions » 08:20
05/26/20
05/26
08:20
05/26/20
08:20
EDNT

Edison Nation

$2.34 /

+0.06 (+2.63%)

Edison Nation is pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDNT Edison Nation
$2.34 /

+0.06 (+2.63%)

Hot Stocks
GTT Communications promotes Ernie Ortega to chief revenue officer » 08:19
05/26/20
05/26
08:19
05/26/20
08:19
GTT

GTT Communications

$9.03 /

-0.02 (-0.22%)

GTT announced that Ernie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.